Cargando…
First performance report of QIAreach™ Anti-SARS-CoV-2 Total Test, an innovative nanoparticle fluorescence digital detection platform
In 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a global pandemic. Disease diagnosis, appropriate clinical management and infection control are all important factors in controlling the spread of SARS-CoV-2. The QIAreach™ Anti-SARS-CoV-2 Total Test (Anti-CoV2) is a rapid,...
Autores principales: | Stieber, Francis, Howard, Jenny, Rao, Sonia N., Kawamura, L. Masae, Manissero, Davide, Love, Joanna, Yang, Mei, Uchiyama, Robin, Parsons, Sean, Miller, Chris, Douwes, Harmony, McDonald, Aaron, Fairburn, Luke, Boyle, Jeffrey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833412/ https://www.ncbi.nlm.nih.gov/pubmed/33160178 http://dx.doi.org/10.1016/j.jcv.2020.104681 |
Ejemplares similares
-
Preliminary Evaluation of QuantiFERON SARS-CoV-2 and QIAreach Anti-SARS-CoV-2 Total Test in Recently Vaccinated Individuals
por: Jaganathan, Soumya, et al.
Publicado: (2021) -
Evaluation of a lateral-flow nanoparticle fluorescence assay for TB infection diagnosis
por: Stieber, F., et al.
Publicado: (2021) -
QIAreach QuantiFERON-TB for the diagnosis of Mycobacterium tuberculosis infection
por: Saluzzo, Francesca, et al.
Publicado: (2022) -
Assessing usability of QIAreach QuantiFERON-TB platform in a high tuberculosis prevalence, low-resource setting
por: Kaaba, Conceptor, et al.
Publicado: (2021) -
Accuracy of interferon gamma release assays for the COVID-19 immunity assessment
por: Stieber, Francis, et al.
Publicado: (2022)